|
 Klaus1250 rated 17 months ago - From the page: "y some people as a â€oegenius pill” for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as â€oechemo-brain,” according to a University of Rochester Medical Center study.
Sixty-eigh...
|
|
1 Reviews
-
-
- Klaus1250 rated 17 months ago
- From the page: "y some people as a â€oegenius pill” for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as â€oechemo-brain,” according to a University of Rochester Medical Center study.
Sixty-eight women, who had completed treatment for breast cancer, participated in an eight-week clinical trial testing the effects of modafinil (Provigil). All women took the drug for the first four weeks. During the next month half of the women continued to receive the drug while the other half took an identical looking placebo pill. The women who took modafinil for all eight weeks reported major improvements in memory, concentration and learning.
â€oeI am very enthusiastic about the potential weâ€ve demonstrated,” said Sadhna Kohli, Ph.D., M.P.H., lead author of the study and a research assistant professor at the University of Rochesterâ€s James P. Wilmot Cancer Center. â€oeThis is a novel drug and after completing the trial, many of the women wanted to know how they could continue to get modafinil.”
Kohli presents the research -- which is believed to be the first to examine the drugâ€s use in breast cancer patients -- on June 3 at the American Society of Clinical Oncology meeting in Chicago. ASCO is honoring Kohli with a Merit Award."
|
